三阴性乳腺癌
癌症研究
转移
中央控制室4
血管生成
乳腺癌
人口
医学
肿瘤进展
肿瘤微环境
癌症
生物
免疫学
趋化因子
趋化因子受体
内科学
免疫系统
肿瘤细胞
环境卫生
作者
Sushil Kumar,David W. Wilkes,Nina Samuel,Andrés Blanco,Anupma Nayak,Kevin Alicea-Torres,Christian Gluck,Satrajit Sinha,Dmitry I. Gabrilovich,Rumela Chakrabarti
摘要
Triple-negative breast cancer (TNBC) is particularly aggressive, with enhanced incidence of tumor relapse, resistance to chemotherapy, and metastases. As the mechanistic basis for this aggressive phenotype is unclear, treatment options are limited. Here, we showed an increased population of myeloid-derived immunosuppressor cells (MDSCs) in TNBC patients compared with non-TNBC patients. We found that high levels of the transcription factor ΔNp63 correlate with an increased number of MDSCs in basal TNBC patients, and that ΔNp63 promotes tumor growth, progression, and metastasis in human and mouse TNBC cells. Furthermore, we showed that MDSC recruitment to the primary tumor and metastatic sites occurs via direct ΔNp63-dependent activation of the chemokines CXCL2 and CCL22. CXCR2/CCR4 inhibitors reduced MDSC recruitment, angiogenesis, and metastasis, highlighting a novel treatment option for this subset of TNBC patients. Finally, we found that MDSCs secrete prometastatic factors such as MMP9 and chitinase 3-like 1 to promote TNBC cancer stem cell function, thereby identifying a nonimmunologic role for MDSCs in promoting TNBC progression. These findings identify a unique crosstalk between ΔNp63+ TNBC cells and MDSCs that promotes tumor progression and metastasis, which could be exploited in future combined immunotherapy/chemotherapy strategies for TNBC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI